Results 21 to 30 of about 47,840 (254)

The Distribution of ESBL-Producing Enterobacteriaceae: Leicestershire UK Compared to Worldwide [PDF]

open access: yes, 2019
open access ...
Reid, R.   +2 more
core   +1 more source

The Anti-Bacterial Effect of Eucalyptus and Medlar Extracts Against Klebsiella Pneumonia in Rasht Hospitals [PDF]

open access: yesJournal of Advanced Biomedical Sciences, 2020
Background & Objective: Klebsiella pneumonia is an opportunistic pathogen in nosocomial infections. Nowadays using plant-based drugs against drug resistant bacterial infections is gaining special importance.
Maryam Basboos   +2 more
doaj  

Lentic and effluent water of Delhi-NCR: a reservoir of multidrug-resistant bacteria harbouring blaCTX-M, blaTEM and blaSHV type ESBL genes

open access: yesJournal of Water and Health, 2021
Antimicrobial resistance is not restricted to clinics but also spreading fast in the aquatic environment. This study focused on the prevalence and diversity of extended-spectrum β-lactamase (ESBL) genes among bacteria from lentic and effluent water in ...
Asghar Ali   +5 more
doaj   +1 more source

Broad-spectrum β-lactamases among Enterobacteriaceae of animal origin: molecular aspects, mobility and impact on public health [PDF]

open access: yes, 2010
Broad-spectrum β-lactamase genes (coding for extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases) have been frequently demonstrated in the microbiota of food-producing animals. This may pose a human health hazard since these genes may be present
Butaye, Patrick   +7 more
core   +1 more source

Characterisation of Extended-Spectrum β-Lactamases among Multidrug Resistant Enterobacteriaceae from Sudan

open access: yesJournal of Pure and Applied Microbiology, 2019
The aim of the present study was to characterize extended-spectrum β-lactamase (ESBLs) genes in multidrug resistant enterobacterial pathogens as well as commensal isolates from the Sudan during the period 2003 to 2007.
Malik I.A, Elhag K.M.
doaj   +1 more source

Expression of plasmid-mediated resistance genes ESBLs and PMQR among uropathogens, isolated from non-dialysis CKD patients with pyelonephritis

open access: yesPočki, 2022
Urinary tract infections (UTIs) are thought to be the most common group of bacterial infections, worldwide. It is estimated that the proportion of UTIs remains at a high level reaching 150 million episodes per year worldwide and accounting for $6 billion
O.І. Chub, S.V. Teslenko, O.V. Chub
doaj   +1 more source

A degenerate PCR-based strategy as a means of identifying homologues of aminoglycoside and ß-lactam resistance genes in the gut microbiota [PDF]

open access: yes, 2014
peer-reviewedBackground: The potential for the human gut microbiota to serve as a reservoir for antibiotic resistance genes has been the subject of recent discussion. However, this has yet to be investigated using a rapid PCR-based approach.
Cotter, Paul D.   +4 more
core   +1 more source

The continuing challenge of ESBLs [PDF]

open access: yesCurrent Opinion in Pharmacology, 2007
Since their first description more than 20 years ago, Escherichia coli and Klebsiella pneumoniae possessing extended-spectrum class A beta-lactamases (ESBLs) continue to thwart our best clinical efforts. In the 'early years' the most common beta-lactamases were of the TEM and SHV varieties.
Federico, Perez   +3 more
openaire   +2 more sources

Extended-Spectrum Beta-Lactamases Producing Enterobacteriaceae in the USA Dairy Cattle Farms and Implications for Public Health

open access: yesAntibiotics, 2022
Antimicrobial resistance (AMR) is one of the top global health threats of the 21th century. Recent studies are increasingly reporting the rise in extended-spectrum beta-lactamases producing Enterobacteriaceae (ESBLs-Ent) in dairy cattle and humans in the
Benti Deresa Gelalcha   +1 more
doaj   +1 more source

ESBLs and resistance to ceftazidime/avibactam and ceftolozane/tazobactam combinations in Escherichia coli and Pseudomonas aeruginosa.

open access: yesJournal of Antimicrobial Chemotherapy, 2019
OBJECTIVES To evaluate the efficacy of the recently launched β-lactam/β-lactamase inhibitor combinations ceftazidime/avibactam and ceftolozane/tazobactam against ESBL-producing Escherichia coli and Pseudomonas aeruginosa strains.
José Manuel Ortiz de la Rosa   +2 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy